Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001562230-22-000071
Filing Date
2022-02-11
Accepted
2022-02-11 11:19:50
Documents
1

Document Format Files

Seq Description Document Type Size
1 SEC SCHEDULE 13G SEC13G_Filing.htm SC 13G/A 16679
  Complete submission text file 0001562230-22-000071.txt   18259
Mailing Address 333 S. HOPE STREET LOS ANGELES CA 90071
Business Address 333 S. HOPE STREET LOS ANGELES CA 90071 213-486-9200
Capital International Investors (Filed by) CIK: 0001562230 (see all company filings)

EIN.: 951411037 | State of Incorp.: DE | Fiscal Year End: 0630
Type: SC 13G/A

Mailing Address 210 EAST GRAND AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 210 EAST GRAND AVENUE SOUTH SAN FRANCISCO CA 94080 (650) 457-2700
Allogene Therapeutics, Inc. (Subject) CIK: 0001737287 (see all company filings)

EIN.: 823562771 | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-90685 | Film No.: 22617883
SIC: 2836 Biological Products, (No Diagnostic Substances)